Reply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States. (2nd November 2017)

Record Type:: Journal Article
Title:: Reply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States. (2nd November 2017)
Main Title:: Reply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States
Authors:: Saint-Laurent Thibault, Catherine
Moorjaney, Divya
Ganz, Michael L.
Sill, Bruce
Hede, Shalini
Yuan, Yong
Gorsh, Boris
Abstract:
Is Part Of:: Journal of medical economics. Volume 20:Number 11(2017)
Journal:: Journal of medical economics
Issue:: Volume 20:Number 11(2017)
Issue Display:: Volume 20, Issue 11 (2017)
Year:: 2017
Volume:: 20
Issue:: 11
Issue Sort Value:: 2017-0020-0011-0000
Page Start:: 1123
Page End:: 1125
Publication Date:: 2017-11-02
Subjects:: Medical care -- Cost control -- Periodicals
Medical economics -- Periodicals
362.10941
Journal URLs:: http://informahealthcare.com/jme ↗
http://informahealthcare.com ↗
DOI:: 10.1080/13696998.2017.1360313 ↗
Languages:: English
ISSNs:: 1369-6998
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5017.049500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 4789.xml